23rd November – 1st December 2020

ART-Plan™ keeps improving

Discover our new AI features that will leverage the benefits of MRI for better treatment planning.

The development of a fully adaptive, AI-powered treatment planning software is urgently needed. We are proud to be introducing our new era of MR-based proudcts that will pave the way towards this vision of radiation therapy on the fly for more efficient, safe and precise treatment for cancer patients.

Professor Nikos Paragyios
CEO & CTO at TheraPanaceaProfessor of Mathematics - University of Paris-Saclay
Editor in Chief, Computer Vision at Elsevier

Start using today the radiotherapy tools of tomorrow
Come meet our experts to bring AI into your daily routine



Our revolutionary AI-based tool for OARs and target volumes contouring

Elsa Dray
Elsa DraySolution ExpertTheraPanacea



The most powerful AI-based rigid and deformable fusion tool for adaptive RT

Sibylle de Vandière
Sibylle de VandièreApplication EngineerTheraPanacea

TheraPanacea on the frontier:
Explore our scientific oral and poster presentations at ESTRO 2020.

Deep learning auto contouring of OAR for HN radiotherapy: a blinded evaluation by clinical expertsVincent Grégoire, Pierre Blanchard, Albina Allajbej, Claire Petit, Nicolas Milhade, France Nguyen, Sofia Bakkar, Geoffroy Boulle, Edouard Romano, Wael Zrafi, Aurélien Lombard, Eugénie Ullmann, Nikos Paragios, Eric Deutsch, Charlotte Robert.
Optimizing the generation of brain pseudo-CT from MRI based on a highly efficient 3D neural networkEmilie Alvarez Andres, Lucas Fidon, Maria Vakalopoulou, Marvin Lerousseau, Alexandre Carré, Roger Sun, Anne Beaudre, Eric Deutsch, Nikos Paragios, Charlotte Robert.
AI-driven quality insurance for delineation in radiotherapy breast clinical trialsS. Rivera, A. Lombard, D. Pasquier, S. Wong , E. Limkin, G. Auzac, J. Blanchecotte, M.E. Chand-Fouché, A. Lamrani-Ghaouti, N. Bonnet, N. Paragios, C. Martineau-Huynh, E. Ullmann, A. Ruffier, E. Deutsch.
Full-body delineation of ROIs through anatomy-preserving deep learning ensemble networksA. Lombard, L. de Vitry, E. Ullmann, R. Marini-Silva, N. Bus, N. Paragios.
Assessment of the generalizability to pediatric protontherapy of a 3D network generating pseudo-CTEmilie Alvarez Andres, Maélie Caussé, Lucas Fidon, Louis Ermeneux, Stéphanie Bolle, Valentine Martin, Nikos Paragios, Eric Deutsch, Ludovic de Marzi, Charlotte Robert.
Are current margins in locally advanced cervical cancers treated by tomotherrapy appropriate?S. Rivera (CR), A. Lombard, D. Pasquier, S. Wong, A. Lamrani-Ghaouti, N. Bonnet, N. Paragios, C. Martineau-Huynh, A. Ruffier.
AI-driven Quality Insurance for organ-at-risk annotations in radiation therapy breast clinical trialsS. Rivera (CR), A. Lombard, D. Pasquier, S. Wong, A. Lamrani-Ghaouti, N. Bonnet, N. Paragios, C. Martineau-Huynh, A. Ruffier.
Dr. Daniela ThorwarthHead of Biomedical Physics Research
University of Tübingen, Germany

What do KOLs think of ART-Plan™?

ART-Plan™ has experienced a very high level of acceptance in the different teams of our department in the University Hospital for Radiation Oncology Tübingen, Germany, as it saves a lot of valuable time that can be used for complex treatment planning tasks and interdisciplinary discussions

Are you ready to reinvent cancer care through AI?

ART-Plan™ - Annotate

An accurate and thorough contouring tool using a deep learning technique for the automatic delineation of 80+ OARs and exclusive models for CTV and lymph nodes.
In 1 click and 2 min, medical experts gain 90% of their time with highly accurate results.

ART-Plan™ - SmartFuse

A reliable AI-fueled software for high-precision rigid & elastic fusion, 4D-CT management and real time deformation.
It is the best-performing image registration software on the market * leading to faster replanning.

(*) as assessed through the POPI test

About us

We are an award-winning medical technology company fighting cancer through innovative AI- and web-based solutions for smarter, standardized and more holistic treatment plans. Our success stems from the combined strength of our top-notch expertise in powerful AI solutions and domain knowledge coming from leading cancer centers all around the world.

We use cookies to recognize visitors. We also use them to measure advertisment campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy.
By tapping ‘accept‘, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.